A recent study has shown that the diagnosis of new-onset type 2 diabetes mellitus is associated with a substantial risk of developing chronic liver disease. Should screening for liver disorders be part of the routine evaluation of patients with type 2 diabetes mellitus?
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The association between metabolic dysfunction-associated steatotic liver disease, cardiovascular and cerebrovascular diseases and the thickness of carotid plaque
BMC Cardiovascular Disorders Open Access 11 November 2023
-
Comparative effect of dipeptidyl-peptidase 4 inhibitors on laboratory parameters in patients with diabetes mellitus
BMC Pharmacology and Toxicology Open Access 21 April 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Moscatiello, S., Manini, R. & Marchesini, G. Diabetes and liver disease: an ominous association. Nutr. Metab. Cardiovasc. Dis. 17, 63–70 (2007).
Cusi, K. Nonalcoholic fatty liver disease in type 2 diabetes mellitus. Curr. Opin. Endocrinol. Diabetes Obes. 16, 141–149 (2009).
Porepa, L., Ray, J. G., Sanchez-Romeu, P. & Booth, G. L. Newly diagnosed diabetes mellitus as a risk factor for serious liver disease. CMAJ 182, E526–E531 (2010).
Adams, L. A. & Angulo, P. Recent concepts in non-alcoholic fatty liver disease. Diabet. Med. 22, 1129–1133 (2005).
Bellentani, S. & Marino, M. Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD). Ann. Hepatol. 8 (Suppl. 1), S4–S8 (2009).
Bellentani, S., Scaglioni, F., Marino, M. & Bedogni, G. Epidemiology of non-alcoholic fatty liver disease. Dig. Dis. 28, 155–161 (2010).
Lazo, M. & Clark, J. M. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin. Liver Dis. 28, 339–350 (2008).
Argo, C. K. & Caldwell, S. H. Epidemiology and natural history of non-alcoholic steatohepatitis. Clin. Liver Dis. 13, 511–531 (2009).
Adams, L. A. Nonalcoholic fatty liver disease and diabetes mellitus. Endocr. Res. 32, 59–69 (2007).
Trauner, M., Arrese, M. & Wagner, M. Fatty liver and lipotoxicity. Biochim. Biophys. Acta 1801, 299–310 (2010).
Acknowledgements
M. Arrese is supported by grants from the Chilean National Commission of Science and Technology (Fondecyt #1080170 and ACT79).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Arrese, M. Liver disease: an overlooked complication of diabetes mellitus. Nat Rev Endocrinol 6, 660–661 (2010). https://doi.org/10.1038/nrendo.2010.173
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2010.173
This article is cited by
-
The association between metabolic dysfunction-associated steatotic liver disease, cardiovascular and cerebrovascular diseases and the thickness of carotid plaque
BMC Cardiovascular Disorders (2023)
-
Comparative effect of dipeptidyl-peptidase 4 inhibitors on laboratory parameters in patients with diabetes mellitus
BMC Pharmacology and Toxicology (2020)
-
Long-Term, Fructose-Induced Metabolic Syndrome-Like Condition Is Associated with Higher Metabolism, Reduced Synaptic Plasticity and Cognitive Impairment in Octodon degus
Molecular Neurobiology (2018)
-
Bile acid supplementation improves established liver steatosis in obese mice independently of glucagon-like peptide-1 secretion
Journal of Physiology and Biochemistry (2014)
